Could reducing inflammation help combat fatigue in people with early-stage breast cancer?

New research reveals that inflammatory responses may play a role in different types of fatigue experienced by many people with cancer. The findings are published in Cancer.

Cancer-related fatigue can be a distressing and persistent burden that causes patients to feel physical, emotional, and/or cognitive tiredness or exhaustion. Activation of inflammatory responses by the tumor itself and/or by cancer treatment is thought to be a key biological driver of this symptom, but inflammatory activity across the cancer continuum has not been thoroughly examined.

To investigate, researchers at the University of California, Los Angeles (UCLA) analyzed protein markers of inflammation in 192 women with early-stage breast cancer who were examined before radiation or chemotherapy and throughout the 18 months after treatment.

At each assessment, women reported on different dimensions of fatigue (general, physical, mental, and emotional) and provided blood that was tested for protein markers of inflammation. These included two pro-inflammatory cytokines (TNF-α and IL-6) and two downstream markers of their activity (sTNF-RII and CRP).

Higher levels of TNF-α, sTNF-RII, and IL-6 were linked with greater general fatigue, which involves feelings of tiredness and exhaustion. These effects remained even after accounting for age, race, education, body mass index, and cancer stage.

Similarly, there was a positive association between physical fatigue, which involves feelings of physical weakness and heaviness, and TNF-α, sTNF-RII, and CRP. Conversely, higher levels of TNF-α and sTNF-RII were associated with lower levels of emotional fatigue. No significant associations between mental (or cognitive) fatigue and inflammatory markers were found.

“Our findings indicate that inflammation plays a role in some aspects of cancer-related fatigue, but not others, and that these effects persist well after treatment,” said lead author Julienne E. Bower, Ph.D., of UCLA.

“This is critical for developing targeted treatments for this common and disabling symptom.”

MedicalXpress

Written by: Sadie Harley

Fact Checked by: Robert Egan

Could reducing inflammation help combat fatigue in people with early-stage breast cancer?

More articles for you...

Important Disclaimer: The articles shared on this blog come from reputable sources and are intended solely for informational purposes. They do not represent the opinions or views of Yes, We Care / The WeCare Independent Pharmacy Network. While we strive to provide accurate and reliable information, we cannot guarantee its completeness or relevance. Readers are encouraged to conduct independent research and seek professional guidance when necessary. Yes, We Care / The WeCare Independent Pharmacy Network assumes no responsibility for decisions made based on the content provided.